Understanding Dry AMD and Geographic Atrophy.” The event featured Dr. David S. Liao, a board-certified ophthalmologist at the Retina-Vitreous Associates Medical Group, who specializes in the medical and surgical treatment of diseases of the retina and vitreous. The hosts discussed a proposed and promising pharmaceutical under investigation for geographic atrophy (GA) using a targeted C3 therapy. There was also discussion about other possible treatment for Age-related Macular Degeneration (AMD) and GA, clinical research, how long eye disease may take to progress, and regular provider visits with optometrists and ophthalmologists.